CA Stock MarketDetailed Quotes
NIRV Nirvana Life Sciences Inc
- 0.075
- 0.0000.00%
15min DelayMarket Closed Aug 30 15:49 ET
3.62MMarket Cap-2500P/E (TTM)
0.000High0.000Low0Volume0.000Open0.075Pre Close0.00Turnover0.08052wk High0.00%Turnover Ratio48.23MShares0.01052wk Low-0.03EPS TTM2.61MFloat Cap0.950Historical HighLossP/E (Static)34.83MShs Float0.010Historical Low-0.04EPS LYR0.00%Amplitude--Dividend TTM-4.41P/B1Lot Size--Div YieldTTM
Nirvana Life Sciences Inc Key Stats
Quarterly+Annual
YOY
| (Q3)Jan 31, 2024 | (Q2)Oct 31, 2023 | (Q1)Jul 31, 2023 | (FY)Apr 30, 2023 | (Q4)Apr 30, 2023 | (Q3)Jan 31, 2023 | (Q2)Oct 31, 2022 | (Q1)Jul 31, 2022 | (FY)Apr 30, 2022 | (Q1)Jan 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -27.57%169.98K | -38.43%168.73K | -27.90%213.83K | 6.10%1.25M | 448.97K | 234.68K | 325.71%274.06K | 374.80%296.59K | 253.16%1.18M | 61.38%100.81K |
| Selling and administrative expenses | -35.40%80.84K | -46.52%84.72K | -25.35%113.67K | 107.77%767.33K | --337.45K | --125.14K | --158.4K | --152.26K | 396.33%369.31K | --21.74K |
| -Selling and marketing expense | --0 | -99.75%167 | -96.25%2.54K | 535.63%248.47K | --50.59K | --62.44K | --67.6K | --67.85K | --39.09K | --9.52K |
| -General and administrative expense | 28.93%80.84K | -6.88%84.55K | 31.65%111.13K | 57.12%518.85K | --286.86K | --62.7K | --90.8K | --84.41K | 343.79%330.22K | --12.22K |
| Research and development costs | -8.17%20.25K | 1.52%20.57K | 106.98%47.17K | -71.47%91.53K | --20.51K | --22.05K | --20.26K | --22.79K | --320.81K | ---- |
| Depreciation and amortization | -46.71%12.21K | --0 | --0 | -0.00%91.64K | --22.91K | --22.91K | --22.91K | --22.91K | --91.65K | ---- |
| -Depreciation | ---- | --0 | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Rent and land expenses | --0 | --0 | --0 | -52.75%34.25K | --0 | --0 | --19.52K | --20.65K | 562.13%72.5K | --1.45K |
| Other operating expenses | -12.24%56.68K | -12.48%63.44K | -44.09%53K | 287.81%299.96K | --68.11K | --64.58K | 12.60%72.49K | 51.74%94.79K | -70.17%77.35K | 26.58%79.07K |
| Operating profit | 27.57%-169.98K | 38.43%-168.73K | 27.90%-213.83K | -6.10%-1.25M | -448.97K | -234.68K | -325.71%-274.06K | -374.80%-296.59K | -253.16%-1.18M | -61.38%-100.81K |
| Net non-operating interest income (expenses) | 0 | 0 | -117.33%-665 | -167.60%-8.34K | -6.22K | -1.26K | -864 | 3.84K | 12.34K | |
| Non-operating interest income | --0 | --0 | --0 | -99.56%54 | --0 | --0 | --54 | --3.84K | --12.34K | ---- |
| Non-operating interest expense | --0 | --0 | --665 | --8.4K | --6.22K | --1.26K | --918 | ---- | --0 | ---- |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 175K | 0 | -901.61%-147K | 94.82%-232.66K | -251K | 0 | 0 | 136.62%18.34K | -43,908.93%-4.49M | 0 |
| Less:Restructuring and mergern&acquisition | ---175K | --0 | --175K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Less:Impairment of capital assets | ---- | ---- | ---- | --251K | ---- | ---- | ---- | ---- | --0 | ---- |
| Less:Other special charges | ---- | ---- | -52.69%-28K | -100.41%-18.34K | --0 | ---- | ---- | -136.62%-18.34K | 43,908.93%4.49M | ---- |
| Other non-operating income (expenses) | ||||||||||
| Income before tax | 102.13%5.02K | 38.63%-168.73K | -31.74%-361.5K | 73.63%-1.49M | -706.19K | -235.94K | -6,046.92%-274.93K | -401.52%-274.41K | -2,122.88%-5.66M | -84.24%-100.81K |
| Income tax | ||||||||||
| Net income | 102.13%5.02K | 38.63%-168.73K | -31.74%-361.5K | 73.63%-1.49M | -706.19K | -235.94K | -6,046.92%-274.93K | -401.52%-274.41K | -2,122.88%-5.66M | -84.24%-100.81K |
| Net income continuous operations | 102.13%5.02K | 38.63%-168.73K | -31.74%-361.5K | 73.63%-1.49M | ---706.19K | ---235.94K | -6,046.92%-274.93K | -401.52%-274.41K | -2,122.88%-5.66M | -84.24%-100.81K |
| Noncontrolling interests | 80.53%-350 | -123.38%-344 | -210.24%-515 | -68.64%-4.16K | -2.04K | -1.8K | -154 | -166 | -2.47K | |
| Net income attributable to the company | 102.30%5.37K | 38.72%-168.39K | -31.63%-360.98K | 73.70%-1.49M | -704.15K | -234.14K | -6,043.59%-274.77K | -401.22%-274.25K | -2,121.91%-5.65M | -84.24%-100.81K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 102.30%5.37K | 38.72%-168.39K | -31.63%-360.98K | 73.70%-1.49M | -704.15K | -234.14K | -6,043.59%-274.77K | -401.22%-274.25K | -2,121.91%-5.65M | -84.24%-100.81K |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 101.11%0.0001 | 65.09%-0.0035 | 0.00%-0.01 | 75.00%-0.04 | -0.02 | -0.01 | -7,242.86%-0.01 | -503.50%-0.01 | -1,976.03%-0.16 | -84.25%-0.0031 |
| Diluted earnings per share | 101.11%0.0001 | 65.09%-0.0035 | 0.00%-0.01 | 75.00%-0.04 | -0.02 | -0.01 | -7,242.86%-0.01 | -503.50%-0.01 | -1,976.03%-0.16 | -84.25%-0.0031 |
| Dividend per share | ||||||||||
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data